Depatuxizumab mafodotinDepatuxizumab mafodotin (INN; development code ABT-414) is an antibody-drug conjugate designed for the treatment of cancer. It is composed of an EGFR IGg1 monoclonal antibody (depatuxizumab) conjugated to the tubulin inhibitor monomethyl auristatin F via a stable maleimidocaproyl link. Read from the Drugbox of the Wikipedia article Depatuxizumab mafodotin, revision 1370568675.

Property

Value

Formula

C6624H10228N1728O2052S42, 148249.42 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.